Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Journal of Crohn's and Colitis Année : 2022

Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study

Fichier non déposé

Dates et versions

hal-03665876 , version 1 (12-05-2022)

Identifiants

  • HAL Id : hal-03665876 , version 1

Citer

F. Poullenot, A. Amiot, M. Nachury, S. Viennot, R. Altwegg, et al.. Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study. Journal of Crohn's and Colitis, 2022, 16 (1), pp.I362-I363. ⟨hal-03665876⟩
28 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More